UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Endocrine reviews, ISSN 0163-769X, 04/2019, Volume 40, Issue 2, pp. 537 - 557
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypertriglyceridemia - drug therapy | Dyslipidemias - genetics | Dyslipidemias - drug therapy | Atherosclerosis - drug therapy | Hypertriglyceridemia - genetics | Atherosclerosis - genetics | Humans | Hypertriglyceridemia - metabolism | Cholesterol - metabolism | Atherosclerosis - metabolism | Triglycerides - metabolism | Atherosclerosis - etiology | Hypertriglyceridemia - etiology | Lipoproteins - metabolism | Dyslipidemias - metabolism | Dyslipidemias - etiology | Complications and side effects | Care and treatment | Hyperlipidemia | Atherosclerosis | Cholesterol, LDL | Development and progression | Triglycerides | Drug therapy | Health aspects | Risk factors | Lipoproteins (low density) | Health risks | Clinical trials | Chylomicrons | Lipids | Cardiovascular disease | Drug development | Epidemiology | Density | Cholesterol | Lipoproteins | Hypertriglyceridemia | Arteriosclerosis | Genetics | Cardiovascular diseases | Health risk assessment
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2016, Volume 91, Issue 5, pp. 649 - 670
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Smoking - adverse effects | United States - epidemiology | Prevalence | Cardiovascular Diseases - prevention & control | Humans | Neoplasms - prevention & control | Cause of Death | Diet - standards | Cognition Disorders - prevention & control | Global Health - statistics & numerical data | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cardiovascular Physiological Phenomena | Depression - epidemiology | Comorbidity | Risk Factors | Health Behavior | American Heart Association | Diabetes Mellitus - prevention & control | Depression - prevention & control | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Exercise - physiology | Cognition Disorders - epidemiology | Neoplasms - epidemiology | Development and progression | Care and treatment | Cardiovascular diseases | Prevalence studies (Epidemiology) | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2015, Volume 115, Issue 1, pp. 21 - 26
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prevalence | Prognosis | Follow-Up Studies | Cardiovascular Diseases - drug therapy | Humans | Male | Time Factors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Cardiovascular Diseases - epidemiology | Sex Distribution | Female | Aged | Retrospective Studies | Texas - epidemiology | Stroke (Disease) | Medical policy | Care and treatment | Analysis | Low density lipoproteins | Cardiac patients | Evidence-based medicine | Coronary heart disease | Statins | Cardiovascular agents | Cardiovascular disease | Heart attacks | Older people | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2014, Volume 64, Issue 22, pp. 2406 - 2425
ACC/AHA Clinical Practice Guideline | adrenergic beta-antagonists | perioperative cardiovascular complications | review | meta-analysis | systematic | noncardiac surgery | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hospitals | Heart attacks | Health risk assessment | Beta blockers | Mortality
Journal Article
European heart journal, ISSN 0195-668X, 04/2020, Volume 41, Issue 40, pp. 3910 - 3912
Journal Article
The American journal of medicine, ISSN 0002-9343, 10/2020, Volume 133, Issue 10, p. e608
Journal Article
The American heart journal, ISSN 0002-8703, 2016, Volume 181, pp. 74 - 82
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Blood Pressure | Physician Assistants | Nurse Practitioners | United States | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Cardiovascular Diseases - therapy | Male | Primary Health Care - standards | Delivery of Health Care - methods | Female | Physicians, Primary Care | Patient Protection and Affordable Care Act | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - metabolism | Ambulatory Care - methods | Diabetes Mellitus - metabolism | Diabetes Mellitus - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, LDL - metabolism | United States Department of Veterans Affairs | Aged | Blood Glucose - metabolism | Quality of Health Care | Medicine | Physicians | Practice | Comparative analysis | Cardiovascular diseases | Epidemiology | Diabetes therapy | Hypertension | Codes | Cardiovascular disease | Metastasis | Primary care | Patients | Fiscal years | Studies | Quality | Diabetes | Chronic illnesses | Patient Protection & Affordable Care Act 2010-US | Uninsured people | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2016, Volume 182, pp. 97 - 102
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | United States - epidemiology | Healthcare Disparities - statistics & numerical data | Guideline Adherence - statistics & numerical data | Rosuvastatin Calcium - therapeutic use | Humans | Middle Aged | Male | Coronary Artery Disease - drug therapy | Coronary Artery Disease - blood | Medication Therapy Management - standards | Veterans Health | American Heart Association | Medication Therapy Management - organization & administration | Anticholesteremic Agents - therapeutic use | Cholesterol, LDL - blood | Female | Aged | Coronary Artery Disease - epidemiology | Atorvastatin Calcium - therapeutic use | Care and treatment | Usage | Cardiac patients | Health care industry | Cardiovascular diseases | Hospitals, Veterans | Statins | Cholesterol | Cardiovascular agents | Cardiovascular disease | Health risk assessment | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2016, Volume 118, Issue 6, pp. 13A - 18A
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prevalence | Risk Assessment | United States | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Cholesterol, LDL - drug effects | Hyperlipoproteinemia Type II - diagnosis | Patient Selection | Hyperlipoproteinemia Type II - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Hypolipidemic Agents - therapeutic use | Hyperlipoproteinemia Type II - drug therapy | Cardiovascular Diseases - diagnosis | Practice Guidelines as Topic | Heart | Care and treatment | Hypercholesterolemia | Low density lipoproteins | Statins | Cardiovascular agents | Heart attacks | Heart surgery | Lipids | Cardiovascular disease | Triglycerides | FDA approval | Family medical history | Medical screening | Low density lipoprotein | Patients | Cholesterol | Diabetes | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article